Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$722K Buy
+12,000
New +$560K 0.01% 744
2025
Q2
Sell
-56,778
Closed -$2.37M 1561
2025
Q1
$2.37M Buy
+56,778
New +$2.95M 0.07% 143
2023
Q4
Sell
-5,857
Closed -$365K 1827
2023
Q3
$365K Buy
5,857
+860
+17% +$57.9K 0.01% 1094
2023
Q2
$369K Buy
+4,997
New +$381K 0.01% 995
2021
Q4
Sell
-2,958
Closed -$231K 1217
2021
Q3
$231K Sell
2,958
-5,347
-64% -$445K 0.01% 882
2021
Q2
$631K Buy
8,305
+2,694
+48% +$188K 0.01% 736
2021
Q1
$361K Buy
+5,611
New +$337K 0.01% 687
2020
Q4
Sell
-8,795
Closed -$350K 917
2020
Q3
$350K Buy
+8,795
New +$367K 0.02% 442

Other funds holding BRKR

Centiva Capital's BRKR Position: Q2 2026 in Review

Centiva Capital opened a new position in Bruker (BRKR) in Q2 2026: 12,000 shares worth $722K. The stake represents 0.01% of the portfolio and ranks #744 among its holdings. This is a return to the name: Centiva Capital previously reported a position in BRKR as recently as Q1 2025.

Centiva Capital first reported a position in BRKR in Q3 2020 and has held it in 8 quarters since. The position peaked at $2.37M in Q1 2025. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Centiva Capital held 12,000 shares of Bruker worth $722K as of Q2 2026.
  • Bruker was a new Centiva Capital position in Q2 2026.
  • Bruker made up 0.01% of Centiva Capital's portfolio in Q2 2026, its #744 holding.
  • Centiva Capital first reported a position in Bruker in Q3 2020 and has held it in 8 quarters since.
  • Centiva Capital's Bruker position peaked at $2.37M in Q1 2025.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.